Join Matindale-Hubbell Connected



Search Results (2672)

  
Documents on biotech life sciences
 

View Page: Prev  1  2  3  4  5  6  7  8  9  10  Next  >>
Show: results per page
Sort by:
Sponsored Results

HTMLThe Year in Mesothelioma
Brayton Purcell LLP;
Legal Alert/Article
January 8, 2014, previously published on January 07, 2014
With the end of 2013 and the beginning of the New Year, there are always many lists discussing aspects of the previous years. Mesothelioma is no different, and one review of the top 10 events associated with mesothelioma highlights a few interesting items.

 

HTMLThe Federal Circuit Wades into FDC Act Preemption and Intended Use in RevitaLash Decision
Kurt R. Karst; Hyman, Phelps & McNamara, P.C.;
Legal Alert/Article
January 6, 2014, previously published on January 2, 2014
Last week, in an unusual move, the U.S. Court of Appeals for the Federal Circuit waded into non-patent territory when the Court issued its decision in Allergan, Inc. v. Athena Cosmetics, Inc. (Case No. 2013-1286), a consolidated appeal of several decisions by the U.S. District Court for the Central...

 

HTMLDecree Guiding Advertising Law in Vietnam Comes into Force
Mai Phuong Nguyen, Thi Mai Nguyen; Mayer Brown JSM Vietnam Limited;
Legal Alert/Article
January 6, 2014, previously published on January 2, 2013
On 21 June 2012 the National Assembly passed the Law on Advertising which, among other things, contains very strict provisions on the advertising of special goods that may have an impact on human health.

 

HTMLFDA Orders Google-Backed Home Genetic Test Service 23andMe to Halt Marketing
Anthony M. Catalfamo; Baker Sterchi Cowden & Rice, L.L.C.;
Legal Alert/Article
January 2, 2014, previously published on December 26, 2013
The U.S. Food and Drug Administration (FDA) ordered Google-backed home genetic test maker 23andMe to “immediately discontinue” its Personal Genome Service (PGS) after failing to undergo proper agency approval for its marketing claims.

 

HTMLHarkonen’s Supreme Court Petition Denied
Anne K. Walsh; Hyman, Phelps & McNamara, P.C.;
Legal Alert/Article
December 27, 2013, previously published on December 20, 2013
With no fanfare, the U.S. Supreme Court on Monday denied a writ of certiorari in a case watched closely by the drug and device industry. As reported earlier, the former CEO of InterMune Inc., Scott Harkonen, had filed a petition asking the Court to review his felony conviction of wire fraud...

 

Adobe PDFFTC Expands Patent Transfer Rights Reporting Rules, Effective December 16, 2013
Julie L. Tersigni, Michael C. Zogby; Drinker Biddle & Reath LLP;
Legal Alert/Article
December 19, 2013, previously published on December 16, 2013
On November 6, 2013, the Federal Trade Commission released final amendments to the Hart-Scott-Rodino Premerger Notification Rules to clarify when a transaction involving the transfer of rights to all or part of a pharmaceutical (including biologics) patent is reportable under the Hart-Scott-Rodino...

 

HTMLRoyal Flush? Trade Groups Challenge a Second Drug Stewardship Program; This Time the Target is King County, Washington
Kurt R. Karst; Hyman, Phelps & McNamara, P.C.;
Legal Alert/Article
December 19, 2013, previously published on December 17, 2013
In a recent Complaint filed in the U.S. District Court for the Western District of Washington (at Seattle), several trade groups - the Pharmaceutical Research and Manufacturers of America (“PhRMA”), the Generic Pharmaceutical Association (“GPhA”), the Biotechnology Industry...

 

HTMLBooz Allen Hamilton’s Priority Recommendations for Device Review Come as No Surprise
Jennifer D. Newberger; Hyman, Phelps & McNamara, P.C.;
Legal Alert/Article
December 18, 2013, previously published on December 16, 2013
As part of the Medical Device User Fee Act of 2012 (MDUFA III) Commitment Letter, FDA and the medical device industry agreed to participate in a comprehensive assessment of the medical device review process. MDUFA III Commitment Letter (April 18, 2012), at 12. FDA contracted with Booz Allen...

 

HTMLALJ Essex Denies Motion to Compel In Certain Omega-3 Extracts from Marine or Aquatic Biomass (337-TA-877)
John F. Presper, Thomas C. Yebernetsky; Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.;
Legal Alert/Article
December 16, 2013, previously published on December 13, 2013
On December 9, 2013, ALJ Theodore R. Essex issued the public version of Order No. 34 (dated November 15, 2013) in Certain Omega-3 Extracts from Marine or Aquatic Biomass and Products Containing the Same (Inv. No. 337-TA-877).

 

HTMLALJ Essex Grants Motion To Compel In Certain Omega-3 Extracts From Marine Or Aquatic Biomass (338-TA-877)
John F. Presper, Thomas C. Yebernetsky; Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.;
Legal Alert/Article
December 16, 2013, previously published on December 12, 2013
On December 9, 2013, ALJ Theodore R. Essex issued the public version of Order No. 35 (dated November 18, 2013) in Certain Omega-3 Extracts from Marine or Aquatic Biomass and Products Containing the Same (Inv. No. 337-TA-877).

 


View Page: Prev  1  2  3  4  5  6  7  8  9  10  Next  >>